Cite
HARVARD Citation
Keystone, E. et al. (2013). AB0267 Five-year safety and efficacy of golimumab in patients with active rheumatoid arthritis despite prior treatment with methotrexate: final study results of the phase 3, randomized placebo-controlled go-forward trial. Annals of the rheumatic diseases. pp. A867-A868. [Online].